Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis

OBJECTIVES: Anti-IL-17/23 biologics are increasingly used to treat psoriasis. We aimed to elucidate characteristics of drug-induced interstitial pneumonia (DIIP) caused by anti-IL-17/23 biologics. METHODS: We retrospectively analyzed the clinical data of psoriasis patients treated with anti-IL-17/23...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyagawa, Hanae, Hara, Hiromichi, Araya, Jun, Minagawa, Shunsuke, Numata, Takanori, Umezawa, Yoshinori, Asahina, Akihiko, Nakagawa, Hidemi, Kuwano, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790374/
https://www.ncbi.nlm.nih.gov/pubmed/33411857
http://dx.doi.org/10.1371/journal.pone.0245284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790374/
https://www.ncbi.nlm.nih.gov/pubmed/33411857
http://dx.doi.org/10.1371/journal.pone.0245284

Ejemplares similares